ALB and neoplasm: Among them, albumin (Alb)-based NPs offer distinct advantages, including high biocompatibility, efficient drug loading capacity, inherent tumor-targeting potential, and facile surface modification (Xiong et al., 2025; Zhang et al., 2013).